Utah Medical Products, Inc. Form 8-K August 19, 2005

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): August 19, 2005


Commission File No. 0-11178


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87-0342734
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)


7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices


Registrant's telephone number: (801) 566-1200

 
 
ITEM 8.01 OTHER EVENTS


On August 22, 2005, Utah Medical Products, Inc. issued a press release announcing that its FDA trial has been postponed. A copy of the press release is attached hereto as Exhibit 99.1



SIGNATURES
 

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
     
     
Date:         8/22/05       
By:
    /s/ Kevin L. Cornwell
   
Kevin L. Cornwell
   
CEO
 
 
 

 

EXHIBIT INDEX

Index
 
Number
Description
   
99.1
Press release issued August 22, 2005: FDA Trial Postponed